Cat. No.: X23-10-ZQ869
ERK inhibitor XMD 17-109, Purity ≥98%
Synonym: XMD17-109; 1435488-37-1; 11-Cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one; XMD17109; 11-Cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one; ERK inhibitor
- CAS Number: 1435488-37-1
- Compound CID: 71604307
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
XMD 17-109, soluble in DMSO and ethanol and insoluble in water, exhibits potent inhibition of ERK kinase. It targets ERK5.
Molecular Formula
C36H46N8O3
Solubility
DMSO: 97 mg/mL (151.84 mM); Water: Insoluble; Ethanol: 97 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
XMD 17-109 can be applied to the study of ERK1/2 inhibition in cancer biology and therapy.
Related Products
